Your browser doesn't support javascript.
loading
Reply to "Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?"
Matsuura, Hiroaki; Fujiwara, Keiichi; Omori, Hiroki; Onishi, Kiriko; Kuribayashi, Tadahiro; Mitsumune, Sho; Takigawa, Yuki; Kudo, Kenichiro; Sato, Akiko; Sato, Ken; Shibayama, Takuo.
Afiliación
  • Matsuura H; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.
  • Fujiwara K; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.
  • Omori H; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.
  • Onishi K; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.
  • Kuribayashi T; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.
  • Mitsumune S; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.
  • Takigawa Y; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.
  • Kudo K; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.
  • Sato A; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.
  • Sato K; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.
  • Shibayama T; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Japan.
Intern Med ; 60(15): 2521, 2021 08 01.
Article en En | MEDLINE | ID: mdl-33583909

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aspergilosis Broncopulmonar Alérgica / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Revista: Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aspergilosis Broncopulmonar Alérgica / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Revista: Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2021 Tipo del documento: Article País de afiliación: Japón